|
|
|
|
Enzo Biochems Clinical Lab Division Enters Exclusive Agreement with Novel Sequencing Provider MultiGEN Diag
Molecular Diagnostics Breaking News News source: Business Wire Enzo Biochem, Inc.(NYSE:ENZ) today announced that it has entered into an agreement with MultiGEN Diagnostics Inc., of San Diego, California, for exclusive rights to market MultiGENs unique...
|
|
|
Enzo to Exclusively Offer Multigen's DNA-Based Antenatal Assays in NY in Second Half of 2010
Enzo Biochem hopes to exclusively market certain antenatal infectious disease tests made by Multigen Diagnostics in New York and New Jersey sometime in the second half of the year, the companies said today.Enzo will also seek CLIA validation for the...
|
|
|
Enzo Biochem to market MultiGENs multiplex DNA sequencing based diagnostic tests in state of New York
Enzo Biochem, Inc.(NYSE:ENZ) today announced that it has entered into an agreement with MultiGEN Diagnostics Inc., of San Diego, California, for exclusive rights to market MultiGENs unique diagnostic tests based on multiplex DNA sequencing, in the state of...
|
|
|
Enzo Biochems Clinical Lab Division Enters Exclusive Agreement with Novel Sequencing Provider MultiGEN Diagnostics, Inc.
NEW YORK--(BUSINESS WIRE)--Enzo Biochem, Inc.(NYSE: ENZ) today announced that it has entered into an agreement with MultiGEN Diagnostics Inc., of San Diego, California, for exclusive rights to market MultiGEN?s unique diagnostic tests based on multiplex DNA...
|
|
|
Enzo Biochems Clinical Lab Division Enters Exclusive Agreement with Novel Sequencing Provider MultiGEN Diag
Companies mentioned in this article: Enzo Biochem, Inc.NEW YORK -- (BUSINESS WIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) today announced that it has entered into an agreement with MultiGEN Diagnostics Inc., of San Diego, California, for exclusive rights to...
|
|
|
Enzo Licenses MultiGen's Dx Panel
NEW YORK (GenomeWeb News) Enzo Biochem said today that it has licensed exclusive rights to market MultiGen Diagnostics' antenatal infectious disease tests in New York and non-exclusive rights to the market them in other US territories.Enzo will validate and...
|
|
|
Screening for asymptomatic thrombophilia reduces provoked VTE risk
MedWire News: Screening asymptomatic relatives of patients with hereditary thrombophilias identifies individuals who may benefit from thromboprophylaxis, Dutch researchers have found.Through screening, relatives may reduce their risk for provoked...
|
|
|
Pregnancy outcomes among women with inherited thrombophilia polymorphisms
Asymptomatic, nulliparous, heterozygous carriers of the prothrombin gene mutatio Pregnancy outcomes among women with inherited thrombophilia polymorphisms.
|
|
|
Inflammatory Bowel Disease-Related Thoracic Aortic Thrombosis
Elder K et al.Thrombophilia was attributed to UC, as hypercoagulable testing was negative. Inflammatory Bowel Disease-Related Thoracic Aortic Thrombosis.
|
|
|
How to evaluate a woman with a third-trimester fetal death
12Next Q.A 24-year-old patient (gravida 1) presents with decreased fetal movement at 32 weeks' gestation and is found to have an intrauterine fetal death. How would you evaluate this patient? Stillbirth (intrauterine fetal death [IUFD]), often defined as...
|
